Apparently Sorrento Therapeutics already has a cure that’s bogged down by testing. I guess they don’t have the connections to fast track it.
Sorrento also got $34 million from DARPA for their treatment, I might add. Is this just a general "Rargh, drugs shouldn't take so much testing!" complaint, or are you asserting that Pfizer, Moderna, and J&J are getting preferential treatment that Sorrento isn't?
Just struck me as odd that it’s bogged down in more testing when it seems to have a near perfect record. Blows my mind that India and Brazil aren’t begging for it considering the scope of their current situations.
After following it for the last year, suddenly seeing the Pfizer option out of nowhere just struck me as odd.
Because this sounds a bit like remdesivir, one of the earlier candidates for a savior drug that, once we had more statistical power, didn’t really pan out.
https://www.nejm.org/doi/full/10.1056/nejmoa2007764
Also, if it’s an IV infusion, in a poorer country with a massively strained health care system…well, good luck actually deploying it.
https://investors.sorrentotherapeutics.com/news-releases/new...
It could indeed fizzle like Remdesivir. Just, yeah, the data, while promising, is so small it tells us nothing. Hence why the clinical trial process.
And from that link…
“All nine patients…”
…and from the parent…
“it’s saved the lives of everybody who it’s been given to so far”
Well, when N=9, whoop-dee-doo.
Also, while that sure could be promising, color me quite surprised if they can up human-derived stem cells to treat a surge like they are seeing in India.